Zeyen T, Bohm L, Paech D, Schafer N, et al. Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ. Neuro Oncol 2024 Oct 1:noae205. doi: 10.1093.
PMID: 39351820